Overview
Dyslipidemia is an abnormality in lipoprotein metabolism
that can cause an increased risk for cardiovascular (CV) diseases. The definition of
dyslipidemia and its prevalence can be found in the Introduction and Epidemiology sections.
Lipids that circulate in the blood in the form of
lipoproteins have effects on CV health and are discussed in the
Pathophysiology section. The Etiology
section enumerates the different factors that predispose the patient to
coronary heart disease caused by dyslipidemia.
The different types of dyslipidemia are
identified and discussed in the Classification
section.
Dyslipidemia_Disease SummaryDiagnosis
Frequency of dyslipidemia screening varies depending on the
age group as presented in the Screening section.
Tests for screening and diagnosis of dyslipidemia in
patients suspected of the condition are discussed in the Laboratory Tests and Ancillaries section.
Diseases that may present similar symptoms to
dyslipidemia and should be ruled out are in the Differential
Diagnosis section.
Management
Categorizing the patients by CV disease (CVD) risk and
risk stratification is performed to evaluate patients with dyslipidemia and
these are discussed in the Evaluation
section.
Lipid treatment goals are identified in the Principles of Therapy section. In this section,
cardiovascular-kidney metabolic syndrome clinical identification and management
are also discussed.
Details about the therapeutic options for lowering LDL-C and
TG and raising HDL-C are in the Pharmacological Therapy section. The treatment of specific types of dyslipidemia
is also discussed in this section.
Lifestyle modification strategies like recommendations on
diet, physical activity, weight loss, alcohol intake and smoking cessation are
discussed in detail in the Nonpharmacological
section.
